AIM ImmunoTech financial statements

에임 이뮤노테크NYSEAMERICAN:AIM · NYSE Amex · Healthcare · sector #17
$0.1828+0.16%
2026-10-07 close · prelim

AIM ImmunoTech's published financial data is dated 2026-10-04. 2024 revenue was $0M. 2024 operating profit was −$20M.

Reported results

AIM ImmunoTech notifications

Quantus Signal · live data · not investment advice · Privacy Policy